NCT01741571

Brief Summary

Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) techniques have not been well studied. The investigators will conduct a randomized study comparing the diagnostic yield and specimen quality of EBUS-FNA performed with and without suction applied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable lung-cancer

Timeline
Completed

Started Dec 2012

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2012

Completed
4 days until next milestone

Study Start

First participant enrolled

December 1, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2012

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

September 21, 2020

Status Verified

September 1, 2020

Enrollment Period

3.1 years

First QC Date

November 27, 2012

Last Update Submit

September 18, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensitivity of each needle aspiration technique for diagnosis of malignancy

    A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The sensitivity for diagnosing malignancy will be calculated and compared for the two needle aspiration technique.

    Diagnosis of malignancy will be ascertained after 6 month clinical follow up

  • Diagnostic accuracy of each needle aspiration technique for diagnosis of malignancy

    A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The diagnostic accuracy for diagnosing malignancy will be assessed and compared for the two needle aspiration technique.

    Diagnosis of malignancy will be ascertained after 6 month clinical follow up

Secondary Outcomes (4)

  • Adequacy of the needle aspiration sample

    Adequacy will be assessed within 1 week from procedure

  • Negative predicted value of each needle aspiration technique for diagnosis of malignancy

    Diagnosis of malignancy will be ascertained after 6 month of clinical follow up

  • Specificity of each needle aspiration technique for diagnosis of malignancy

    Diagnosis of malignancy will be ascertained after 6 month clinical follow up

  • Positive predicted value of each needle aspiration technique for diagnosis of malignancy

    Diagnosis of Malignancy will be ascertained after 6 month of clinical follow up

Study Arms (2)

EBUS guided FNA with suction

ACTIVE COMPARATOR

Device/procedure: lymph node tissue collection using fine needle aspiration with suction applied. Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.

Device: EBUS guided FNA with and without suction

EBUS guided FNA without suction

EXPERIMENTAL

Device/procedure: lymph node tissue collection using fine needle aspiration without suction applied. Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.

Device: EBUS guided FNA with and without suction

Interventions

Device/procedure: lymph node tissue collection using needle with and without suction applied. Four fine needle aspirations will be taken from each lymph node. Two with suction and two without suction applied.

EBUS guided FNA with suctionEBUS guided FNA without suction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult undergoing EBUS at AUBMC for suspected malignancy

You may not qualify if:

  • Coagulopathy
  • The lesion cannot be sampled because of intervening tumor or blood vessels.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American University of Beirut

Beirut, Lebanon

Location

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Suction

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

DrainageSurgical Procedures, Operative

Study Officials

  • Hassan Chami, MD

    American University of Beirut Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 27, 2012

First Posted

December 5, 2012

Study Start

December 1, 2012

Primary Completion

January 1, 2016

Study Completion

January 1, 2017

Last Updated

September 21, 2020

Record last verified: 2020-09

Locations